In 2014, the development of new products was initiated, further enhancing Alvotech’s pipeline of biosimilar candidates. The company entered a partnership with Finesse Solutions, which provided Alvotech laboratory and manufacturing technology via its turnkey SmartFactory GMP manufacturing platform suite.